🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521020-30-00
Authorised Phase I

A Phase 1 study to evaluate the effect of BV100 on the pharmacokinetics of polymyxin B in healthy volunteers

2025-521020-30-00 · tracked via the Priya Life Science EU tracker
Sponsor
Bioversys S.A.S.
Sponsor type
Pharmaceutical company
Therapeutic area
Respiratory Tract Diseases
Decision date
01/03/2026
Enrollment target
16
Sites
Austria

Condition studied

Healthy volunteer trial. Intended indication: treatment of infections due to A. baumannii.

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521020-30-00 on CTIS ↗ ← All trials in the EU